M. H. Carnegie & Co.

M.H. Carnegie & Co. is an alternative asset manager founded in 2011 and headquartered in Sydney, Australia. The firm manages funds in excess of AUD $900 million across eight investment platforms, serving institutional, wholesale, and high-net-worth investors. It holds an Australian Financial Services Licence (AFSL No. 411216). The firm invests across a broad range of asset classes, including venture capital, private equity, and real estate. Its differentiated approach centers on building platform businesses in partnership with established industry leaders who bring deep sector knowledge and networks. The firm also has an active interest in digital assets, having partnered with Blockchain Assets Pty Ltd to offer crypto and decentralized finance exposure as a fund-of-funds strategy for Australian investors. M.H. Carnegie & Co. invests across several sectors, including medical technology, fast-moving consumer goods, operating real estate, specialized industry solutions, debt, and service businesses. Its operating real estate platform has a particular focus on hospitality and entertainment assets, having invested in some of Sydney's most iconic venues, including Kinselas Hotel, The Steyne Hotel, The Marlborough Hotel, and The Entertainment Quarter. Portfolio companies and investments span a wide range of industries, including Cardiac Dimensions, EBR Systems, Minomic, Simplify Medical, Serene Medical, Saleslink Group, Health Lab, Assetic, Lonsec, and The Career Group, among others.